Visible-light-responsive novel Ru (II)-metallo-antibiotics with potential antibiofilm and antibacterial activity

AA Mandal, A Upadhyay, A Mandal… - … Applied Materials & …, 2024‏ - ACS Publications
Growing challenges with antibiotic resistance pose immense challenges in combating
microbial infections and biofilm prevention on medical devices. Lately, antibacterial …

Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru (II) Photocatalysts

AA Mandal, V Singh, S Saha, S Peters… - Inorganic …, 2024‏ - ACS Publications
The relentless increase in drug resistance of platinum-based chemotherapeutics has
opened the scope for other new cancer therapies with novel mechanisms of action (MoA) …

Photodynamic therapy photosensitizers and photoactivated chemotherapeutics exhibit distinct bioenergetic profiles to impact ATP metabolism

RJ Mitchell, D Havrylyuk, AC Hachey, DK Heidary… - Chemical …, 2025‏ - pubs.rsc.org
Energy is essential for all life, and mammalian cells generate and store energy in the form of
ATP by mitochondrial (oxidative phosphorylation) and non-mitochondrial (glycolysis) …

Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt (ii)-induced nucleolar stress

AS Guerrero, PD O'Dowd, HC Pigg, KR Alley… - RSC Chemical …, 2023‏ - pubs.rsc.org
Pt (II) chemotherapeutic complexes have been used as predominant anticancer drugs for
nearly fifty years. Currently there are three FDA-approved chemotherapeutic Pt (II) …

Click-capable phenanthriplatin derivatives as tools to study Pt (II)-Induced nucleolar stress

PD O'Dowd, AS Guerrero, KR Alley, HC Pigg… - ACS Chemical …, 2024‏ - ACS Publications
It is well established that oxaliplatin, one of the three Pt (II) anticancer drugs approved
worldwide, and phenanthriplatin, an important preclinical monofunctional Pt (II) anticancer …